Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Moodys
Healthtrust
AstraZeneca
US Army
Johnson and Johnson
McKinsey
Queensland Health
Fish and Richardson

Generated: July 16, 2018

DrugPatentWatch Database Preview

Aurobindo Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for AUROBINDO PHARM, and what generic and branded alternatives to AUROBINDO PHARM drugs are available?

AUROBINDO PHARM has three hundred and nineteen approved drugs.

There are thirty-four tentative approvals on AUROBINDO PHARM drugs.

Drugs and US Patents for Aurobindo Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd NIACIN niacin TABLET, EXTENDED RELEASE;ORAL 209236-003 Feb 1, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma Ltd NAPROXEN SODIUM naproxen sodium TABLET;ORAL 200629-001 Oct 31, 2011 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma Ltd CEPHALEXIN cephalexin CAPSULE;ORAL 065253-001 Nov 16, 2005 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma Ltd CLOZAPINE clozapine TABLET;ORAL 206433-004 Nov 29, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for AUROBINDO PHARM drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Merck
Boehringer Ingelheim
Harvard Business School
Fish and Richardson
McKesson
Cipla
Teva
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.